| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 53.49B | 53.69B | 56.47B | 67.54B | 54.43B | 67.68B |
| Gross Profit | 17.33B | 17.58B | 18.09B | 21.49B | 15.45B | 22.79B |
| EBITDA | 5.54B | 6.79B | 5.40B | 9.84B | 8.94B | 16.30B |
| Net Income | 3.97B | 3.59B | 4.27B | 6.71B | 5.03B | 9.65B |
Balance Sheet | ||||||
| Total Assets | 85.31B | 74.98B | 76.26B | 78.87B | 75.91B | 55.47B |
| Cash, Cash Equivalents and Short-Term Investments | 35.17B | 33.78B | 34.82B | 33.39B | 26.89B | 16.86B |
| Total Debt | 9.44B | 4.24B | 4.37B | 4.64B | 6.85B | 5.44B |
| Total Liabilities | 21.79B | 13.86B | 15.31B | 19.69B | 21.78B | 20.68B |
| Stockholders Equity | 57.76B | 55.47B | 55.10B | 53.83B | 48.57B | 29.62B |
Cash Flow | ||||||
| Free Cash Flow | 3.84B | 4.79B | 6.82B | 13.32B | -6.41B | 6.17B |
| Operating Cash Flow | 5.17B | 6.06B | 7.94B | 15.13B | -3.42B | 8.33B |
| Investing Cash Flow | -5.11B | -3.48B | -454.30M | -4.72B | -3.81B | -2.32B |
| Financing Cash Flow | -3.86B | -3.18B | -4.37B | -4.63B | 15.45B | -3.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$34.59B | -69.15 | 11.27% | 3.18% | 26.38% | -53.61% | |
64 Neutral | HK$346.84B | 13.49 | 8.57% | 3.48% | 12.29% | -67.34% | |
62 Neutral | HK$2.73B | 9.74 | 8.16% | 4.75% | -3.18% | -36.46% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | HK$130.70B | 12.75 | 6.39% | 1.81% | 1.12% | 5.68% | |
54 Neutral | HK$2.53T | 19.21 | 9.95% | 1.34% | 4.59% | -16.23% | |
50 Neutral | HK$507.27B | -9.80 | -13.59% | ― | 8.12% | -166.15% |